Novonesis (Novozymes) A/S (CO:NSIS-B) — Market Cap & Net Worth
Market Cap & Net Worth: Novonesis (Novozymes) A/S (NSIS-B)
Novonesis (Novozymes) A/S (CO:NSIS-B) has a market capitalization of $24.98 Billion (Dkr159.63 Billion) as of June 15, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #1070 globally and #7 in its home market, demonstrating a 5.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Novonesis (Novozymes) A/S's stock price Dkr387.00 by its total outstanding shares 412484967 (412.48 Million). Review Novonesis (Novozymes) A/S (NSIS-B) total liabilities to assess the company's total debt and financial obligations.
Novonesis (Novozymes) A/S Market Cap History: 2015 to 2026
Novonesis (Novozymes) A/S's market capitalization history from 2015 to 2026. Data shows growth from $18.54 Billion to $24.98 Billion (4.60% CAGR).
Index Memberships
Novonesis (Novozymes) A/S is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
STOXX Europe Mid 200 EUR Price
MCXP
|
$1.48 Trillion | 1.68% | #14 of 157 |
|
STOXX Europe Mid 200 EUR Net Return
MCXR
|
$1.48 Trillion | 1.68% | #14 of 157 |
Weight: Novonesis (Novozymes) A/S's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Novonesis (Novozymes) A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Novonesis (Novozymes) A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.33x
Novonesis (Novozymes) A/S's market cap is 6.33 times its annual revenue
Latest Price to Earnings (P/E) Ratio
45.13x
Novonesis (Novozymes) A/S's market cap is 45.13 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $13.82 Billion | $14.14 Billion | $3.05 Billion | 0.98x | 4.53x |
| 2017 | $20.43 Billion | $14.53 Billion | $3.12 Billion | 1.41x | 6.55x |
| 2018 | $17.00 Billion | $14.39 Billion | $3.23 Billion | 1.18x | 5.27x |
| 2019 | $19.37 Billion | $14.37 Billion | $3.15 Billion | 1.35x | 6.14x |
| 2020 | $21.08 Billion | $14.01 Billion | $2.83 Billion | 1.50x | 7.46x |
| 2021 | $32.82 Billion | $14.95 Billion | $3.15 Billion | 2.20x | 10.43x |
| 2022 | $21.78 Billion | $2.36 Billion | $493.36 Million | 9.25x | 44.16x |
| 2023 | $23.72 Billion | $17.90 Billion | $3.02 Billion | 1.33x | 7.84x |
| 2024 | $26.31 Billion | $3.83 Billion | $305.56 Million | 6.87x | 86.11x |
| 2025 | $26.32 Billion | $4.15 Billion | $583.16 Million | 6.33x | 45.13x |
Competitor Companies of NSIS-B by Market Capitalization
Companies near Novonesis (Novozymes) A/S in the global market cap rankings as of June 15, 2026.
Key companies related to Novonesis (Novozymes) A/S by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #94 globally with a market cap of $210.18 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #242 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #254 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #338 globally with a market cap of $78.66 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #94 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $523.57 |
| #242 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #254 | Air Liquide SA | PA:AI | $101.06 Billion | €168.30 |
| #338 | Sherwin-Williams Co | NYSE:SHW | $78.66 Billion | $317.30 |
Novonesis (Novozymes) A/S Historical Marketcap From 2015 to 2026
Between 2015 and today, Novonesis (Novozymes) A/S's market cap moved from $18.54 Billion to $ 24.98 Billion, with a yearly change of 4.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr24.98 Billion | -5.10% |
| 2025 | Dkr26.32 Billion | +0.02% |
| 2024 | Dkr26.31 Billion | +10.91% |
| 2023 | Dkr23.72 Billion | +8.90% |
| 2022 | Dkr21.78 Billion | -33.63% |
| 2021 | Dkr32.82 Billion | +55.73% |
| 2020 | Dkr21.08 Billion | +8.80% |
| 2019 | Dkr19.37 Billion | +13.95% |
| 2018 | Dkr17.00 Billion | -16.77% |
| 2017 | Dkr20.43 Billion | +47.75% |
| 2016 | Dkr13.82 Billion | -25.45% |
| 2015 | Dkr18.54 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 15th, 2026 the market cap of Novonesis (Novozymes) A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $24.98 Billion USD |
| MoneyControl | $24.98 Billion USD |
| MarketWatch | $24.98 Billion USD |
| marketcap.company | $24.98 Billion USD |
| Reuters | $24.98 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Novonesis (Novozymes) A/S
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The c… Read more